Real-world effectiveness of a topical dihydroavenanthramide D formulation for chronic pruritus: A multicenter clinical study with molecular evidence of pruritogenic pathway modulation. [PDF]
Ribero S +6 more
europepmc +1 more source
Real‐World Outcomes of Rituximab in Pemphigus: An Australian Tertiary Cohort
ABSTRACT Rituximab is endorsed internationally as first‐line therapy for moderate‐to‐severe pemphigus, but Australian guidelines position it as a rescue agent and local outcome data are limited. In this single‐centre retrospective cohort, 24 adults with pemphigus vulgaris (n = 16) or pemphigus foliaceus (n = 8) received rituximab as part of routine ...
Pokphazz Christjaroon +4 more
wiley +1 more source
A Traditional Herbal Formula Attenuates Chronic Pruritus by Inhibiting IgE—FcεRI Signaling and Sensory Neuron Activation 2333596 [PDF]
Bongkyun Park +5 more
openalex +1 more source
Rectal Neuroendocrine Tumor Presenting as Refractory Chronic Pruritus Ani: A Case Report. [PDF]
Tran TM +6 more
europepmc +1 more source
Acute Cutaneous Kava Toxicity: A Multicentre Case Series From South Australia
ABSTRACT Kava (piper methysticum) is a traditional beverage of Pacific Island communities which in 2021, re‐entered the Australian market, primarily promoted as an anxiolytic ‘wellness’ product. Emerging cases of acute kava toxicity have occurred since, characterised by a distinctive cutaneous morphology, with or without systemic manifestations.
Zoe Lee +3 more
wiley +1 more source
Knowledge, Attitudes, and Practices of Dermatologists on Chronic Pruritus and Its Management. [PDF]
Talwar A +8 more
europepmc +1 more source
ABSTRACT Basophils, the least abundant leukocytes, are increasingly recognised as potent immunomodulators. Upon activation, they rapidly release preformed granule‐associated mediators including histamine and lipid mediators such as LTC4, while cytokine production occurs over a longer timescale, contributing to downstream immune responses.
Jitesh Chauhan +5 more
wiley +1 more source
Serum‐Proteomic Profiling Reveals Distinct Atopic Dermatitis Severity‐Linked Signatures
This study aimed to identify a set of serum biomarkers that robustly distinguish prespecified severe from mild atopic dermatitis groups. Serum proteomic profiling distinguishes severe from mild atopic dermatitis, revealing an epithelial enriched severity footprint linked to LDH‐associated tissue injury and Th2/Th22 inflammation.
Jag S. Lally +6 more
wiley +1 more source
The effect of medication use on chronic pruritus in patients with type 2 diabetes mellitus: a multicenter cross-sectional study. [PDF]
Xu M +10 more
europepmc +1 more source

